|
|
|
|
NAC is associated with additional alleviation of lung injury induced by invasive pulmonary aspergillosis in a
Peng Xu1,$, Jie-ming Qu2, Jin-fu Xu3, Jing Zhang1, Hong-ni Jiang1 and Hui-jun Zhang1 1Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China 2Department of Pulmonary Medicine, Huadong...
|
|
|
An Alternative Echocardiographic Method to Estimate Mean Pulmonary Artery Pressure: Diagnostic and Clinical Im
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Journal of The American Society of Echocardiography, 07/02/09 Print Save in My Library Free Abstract Aduen JF et al.- MPAP calculated using the proposed...
|
|
|
Pulmonary function testing in patients with pulmonary arterial hypertension
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Respiratory Medicine, 07/02/09 Print Save in My Library Free Abstract Jing ZC et al.- Airway obstruction is common in IPAH, CHD-PAH and CTD-PAH patients....
|
|
|
Anemia increases PE mortality risk
MedWire News: Pulmonary embolism (PE) patients with low levels of hemoglobin (Hb) have a greater risk of dying than their counterparts without anemia, research suggests.David Jimnez Castro (Ramn y Cajal Hospital, Madrid, Spain) and...
|
|
|
June 2009 Briefing - Critical Care
Here are what the editors at HealthDay consider to be the most important developments in Critical Care for June 2009.This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes...
|
|
|
Medical News: New Product For Pfizer Specialty Takes Pulmonary Arterial Hypertension To Heart
Product For Pfizer Specialty Takes Pulmonary Arterial To Heart News Arce [] Web Wikipedia Medical Dictionary [] News New Product For Pfizer Specialty Takes Pulmonary Arterial To Heart Main Category: Also Included In:...
|
|
|
New Product For Pfizer Specialty Takes Pulmonary Arterial Hypertension To Heart
Pfizer Australia announced that it has signed an agreement to acquire the local distribution rights for THELIN (Sitaxentan sodium), an oral, once-daily highly selective endothelin receptor antagonist, indicated for the treatment of pulmonary...
|
|
|
MPs Debate 'Blatant Discrimination' Of Oyxgen Users, UK
Yesterday MPs debated the discrimination that people with a lung condition can experience when they travel on planes.People with lung conditions such as Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary...
|
|
|
Cystic Fibrosis Treatment May Cause Hearing Loss
THURSDAY, July 2 (HealthDay News) -- A common antibacterial treatment for cystic fibrosis can cause sensorineural hearing loss, finds a new study.Researchers reviewed the medical records of 50 cystic fibrosis patients treated over a 13...
|
|
|
June 2009 Briefing - Pulmonology
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for June 2009.This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes...
|
|
|
Researchers Find a Way to Reduce Radiation During Pulmonary CT Angiography
While screening for possible pulmonary emboli using pulmonary CT angiography, a new study shows that radiologists can effectively lower the patient radiation dose by approximately 44% and improve vascular enhancement without deterioration o...
|
|
|
Pulmonary Fungal Infections in Kidney Transplant Recipients: An 8-Year Study
Print Save in My Library Free Abstract Sharifipour F et al.- Fungal infections are among the most important causes of mortality among transplant patients, of which the most common manifestation is pulmonary. Immunosuppressive therapy...
|
|
|
Clinical Trials Update: July 1, 2009
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com and CenterWatch: This trial is for people with chronic low back pain.Qualified participants must be at least 18, and have had low back pain for at...
National Womens Health Information Center:
Jul 1 2009 6:28PM
Matching: pulmonary disease
|
Find similar documents
|
|
|
|
American Academy of Orthopaedic Surgeons Clinical Practice Guideline on. Prevention of Symptomatic Pulmonary E
_ American Academy of Orthopaedic Surgeons Clinical Practice Guideline on.Prevention of Symptomatic Pulmonary E.
|
|
|
New life sciences study findings have been reported by researchers at Carleton University
According to recent research published in the Journal of Aerosol Medicine and Pulmonary Drug Delivery, 'Pressurized metered dose inhalers (pMDIs) are widely used to deliver aerosolized medications to the lungs, most often to relieve...
|
|
|
Research reports from G.J.M. Garcia and co-authors provide new insights into drug delivery
According to recent research published in the Journal of Aerosol Medicine and Pulmonary Drug Delivery, 'Interindividual variability in nasal filtration is significant due to interindividual differences in nasal anatomy and breathing...
|
|
|
Researchers from AstraZeneca publish findings in drug delivery
'A combination of the corticosteroid budesonide and the long-acting beta 2-adrenergic agonist formoterol is available in the United States in a single hydrofluoroalkane pressurized metered-dose inhaler (pMDI) for treatment of persistent...
|
|
|
Researchers Find A Way To Reduce Patient Radiation Dose During Pulmonary CT Angiography
While screening for possible pulmonary emboli using pulmonary CT angiography, a new study shows that radiologists can effectively lower the patient radiation dose by approximately 44% and improve vascular enhancement without deterioration of...
|
|
|
Improving Use of Therapies in the Management of Chronic Obstructive Pulmonary Disease
_ Improving Use of Therapies in the Management of Chronic Obstructive Pulmonary Disease.
|
|
|
Clinical Trials Update: June 30, 2009
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com: Chronic Obstructive Pulmonary Disease (COPD) If you are at least 40 and a current or former smoker with chronic...
National Womens Health Information Center:
Jun 30 2009 9:31PM
Matching: pulmonary disease
|
Find similar documents
|
|
|
|
Interferon Gamma-1b No Help to Pulmonary Fibrosis Patients
TUESDAY, June 30 (HealthDay News) -- Treating idiopathic pulmonary fibrosis patients with interferon gamma-1b does not improve their chances of survival, according to a study published online June 30 in The Lancet.Talmadge E. King Jr.,...
|
|
|
Surgical Resection of Pulmonary Malignant Tumors After Living Donor Liver Transplantation
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Annals of Thoracic Surgery, 06/30/09 Print Save in My Library Free Abstract Shoji F et al.- The results suggest a surgical resection of pulmonary...
|
|
|
Idiopathic Pulmonary Fibrosis
In The Lancet today, Talmadge King and colleagues report the results of the INSPIRE trial with interferon gamma-1b in idiopathic pulmonary fibrosis.1 The investigators randomised 826 patients to receive interferon gamma-1b or placebo in a...
|
|
|
Interferon No Help in Idiopathic Pulmonary Fibrosis
Patients with idiopathic pulmonary fibrosis do not benefit from treatment with interferon gamma-1b, according to a Lancet study released online.Researchers randomized some 800 patients with mild-to-moderate disease in an international,...
|
|
|
Rex Medical Option Retrievable Vena Cava Filter Receives 510k Clearance and CE Mark Approval
- (NewsRx.com) -- Rex Medical, L.P.announced that it has received 510(k) Clearance from the U.S. Food and Drug Administration (FDA) along with CE Mark Approval for the Option Retrievable Vena Cava Filter in the prevention of recurrent ...
|
